Log In
Print
BCIQ
Print
Print this Print this
 

Coartem, artemether/lumefantrine

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionFixed-dose artemisinin-based combination treatment
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentMarketed
Standard IndicationMalaria
Indication DetailsTreat malaria
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today